Westfield Capital Management
IART icon

Westfield Capital Management’s Integra LifeSciences IART Stock Holding History

Westfield Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,980
Closed -$1.59M – 251
2021
Q1 		$1.59M Hold
22,980
– – 0.01% 216
2020
Q4 		$1.49M Hold
22,980
– – 0.01% 225
2020
Q3 		$1.08M Hold
22,980
– – 0.01% 217
2020
Q2 		$1.08M Hold
22,980
– – 0.01% 216
2020
Q1 		$1.03M Sell
22,980
-368,919
-94% -$19.4M 0.01% 210
2019
Q4 		$22.8M Sell
391,899
-3,478
-0.9% -$207K 0.16% 153
2019
Q3 		$23.8M Sell
395,377
-274,440
-41% -$16.4M 0.19% 142
2019
Q2 		$37.4M Sell
669,817
-27,374
-4% -$1.41M 0.28% 120
2019
Q1 		$38.8M Sell
697,191
-33,165
-5% -$1.69M 0.3% 108
2018
Q4 		$32.9M Sell
730,356
-8,640
-1% -$474K 0.28% 113
2018
Q3 		$48.7M Buy
738,996
+91,395
+14% +$5.68M 0.34% 96
2018
Q2 		$41.7M Sell
647,601
-106,465
-14% -$6.59M 0.31% 103
2018
Q1 		$41.7M Sell
754,066
-461,320
-38% -$24.2M 0.32% 107
2017
Q4 		$58.2M Buy
1,215,386
+374,830
+45% +$18.3M 0.44% 86
2017
Q3 		$42.4M Buy
840,556
+45,840
+6% +$2.35M 0.33% 111
2017
Q2 		$43.3M Buy
794,716
+111,091
+16% +$5.3M 0.37% 97
2017
Q1 		$28.8M Sell
683,625
-12,667
-2% -$541K 0.25% 131
2016
Q4 		$29.9M Sell
696,292
-142,428
-17% -$5.79M 0.26% 125
2016
Q3 		$34.6M Sell
838,720
-191,660
-19% -$8.03M 0.28% 122
2016
Q2 		$41.1M Sell
1,030,380
-110,330
-10% -$3.97M 0.34% 101
2016
Q1 		$38.4M Buy
1,140,710
+275,820
+32% +$8.59M 0.29% 108
2015
Q4 		$29.3M Buy
864,890
+254,340
+42% +$7.95M 0.2% 146
2015
Q3 		$18.2M Buy
+610,550
New +$19.1M 0.13% 182

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management's IART Position: Q2 2021 in Review

Westfield Capital Management sold out of Integra LifeSciences (IART) in Q2 2021, closing a stake of 22,980 shares — an estimated $1.59M sold.

Westfield Capital Management first reported a position in IART in Q3 2015 and held it in 23 quarters. The position peaked at $58.2M in Q4 2017. 264 funds tracked by Wall St. Rank hold IART as of Q2 2021.

  • Westfield Capital Management reported no remaining Integra LifeSciences position as of Q2 2021 after selling out during the quarter.
  • Westfield Capital Management sold 22,980 Integra LifeSciences shares in Q2 2021, an estimated $1.59M.
  • Westfield Capital Management first reported a position in Integra LifeSciences in Q3 2015 and held it in 23 quarters.
  • Westfield Capital Management's Integra LifeSciences position peaked at $58.2M in Q4 2017.
  • 264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2021.

Based on Westfield Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.